Mediwound Ltd (MDWD) Live Share Price, Invest From India

Mediwound Ltd Stock Performance

as on December 2, 2025 at 2:29 am IST

Day's Low
Day's High
$17.12
Day's Price Range
$17.93
$17.2
0.47%
Downside
4.24%
Upside
52 Week's Low
52 Week's High
$14.14
52-Week Price Range
$22.51
$17.2
17.79%
Downside
30.84%
Upside

Mediwound Ltd share price movements today

Previous Close: $17.92
Open: $17.70
Volume: 286.2K
Day's Low - High: $17.12 - $17.93
52 Week Low - High: $14.14 - $22.51

Mediwound Ltd Historical Returns

1 Month Return: -2.24 %
3 Month Return: + 7.31 %
1 Year Return: + 2.58 %
3 Year Return: + 66.23 %
5 Year Return: -30.62 %

Mediwound Ltd Stock Fundamentals & Key Indicators

Check Mediwound Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$229.8M

EPS (TTM)

-2.128

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-8.47

Industry PE ratio

PEG Ratio

-0.07

EBITDA

-22.7M

Revenue (TTM)

20.9M

Profit Margin

-98.43%

Return On Equity TTM

-48.83%

Mediwound Ltd Stock Valuation

Track how Mediwound Ltd P/E has moved over time to understand its valuation trends.

Mediwound Ltd in the last 5 years

Overview
Trends

Lowest (-15.23x)

March 31, 2021

Industry (0.00x)

December 1, 2025

Today (-8.47x)

December 1, 2025

Highest (-2.68x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -8.47x

Mediwound Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mediwound Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Mediwound Ltd	BUY	$229.8M	-30.62%	-8.47	-98.43%
Insmed Incorporated	BUY	$44.3B	430.84%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$59.6B	241.14%	1410.09	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$111.2B	88.28%	30.49	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$82.7B	51.77%	18.69	32.13%

Stock Returns calculator for Mediwound Ltd Stock including INR - Dollar returns

The Mediwound Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Mediwound Ltd investment value today

Current value as on today

₹1,04,058

Returns

₹4,058

(+4.06%)

Returns from Mediwound Ltd Stock

₹1,546 (-1.55%)

Dollar Returns*

₹5,604 (+5.6%)

Analyst Recommendation on Mediwound Ltd Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Mediwound Ltd. Average target price of $31.5

Mediwound Ltd Share Price Target

Get share price movements and forecasts by analysts on Mediwound Ltd.

What analysts predicted

45.4%UPSIDE

Target Price

$31.5

Current Price

$17.2

Analyzed by

10 Analysts

Target

$31.50

Mediwound Ltd target price $31.5, a slight upside of 45.4% compared to current price of $17.2. According to 10 analysts rating.

Mediwound Ltd Stock’s Investor Sentiment and Interest

Search interest for Mediwound Ltd Stock has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Time period: November 2, 2025 to December 2, 2025

Change:-60% versus previous 30 day period

Mediwound Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	4	4	5	4	5	4	5	3	5	5
Gross Profit	1	0	0	0	0	0	0	0	1	0
Operating Income	-4	-3	-3	-3	-4	-5	-6	-5	-5	-6
EBITDA	2	-1	-1	-3	-3	-4	-3	0	-4	-2
Interest Expense	0	-	5	5	2	5	-	-	7	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	0	-2	-1	-9	-6	-10	-3	0	-13	-2
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	0	-2	-1	-9	-6	-10	-3	0	-13	-2
Net Profit Margin	19.19%	-45.98%	-32.65%	-195.99%	-124.53%	-236.10%	-66.92%	-18.36%	-233.32%	-48.85%

Mediwound Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	1	2	3	31	21	23	26	18	20
Gross Profit	-2	0	0	1	19	7	8	12	2	1
Operating Income	-21	-20	-13	-10	5	-8	-11	-7	-15	-19
EBITDA	-21	-18	-13	-5	3	-7	-12	-18	-4	-28
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	0	0	1	1	1	1	1	1
Income Before Tax	-21	-18	-14	-5	2	-9	-13	-19	-6	-30
Income Tax Expense	0	-1	8	-9	-1	0	0	0	0	0
Net Income	-22	-18	-22	-1	4	-9	-13	-19	-6	-30
Net Profit Margin	-3675.21%	-1212.13%	-887.38%	-31.08%	15.59%	-42.26%	-57.03%	-73.97%	-35.94%	-149.46%

Mediwound Ltd Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-2	-1	-9	-6	-10	-3	0	-13	-2
Operating Cash Flow	-3	-1	-4	-3	-3	-1	-4	-5	-2
Investing Cash Flow	-5	4	-2	2	-14	4	-3	4	3
Financing Cash Flow	0	0	0	0	20	0	0	0	31
Change in Cash	-9	2	23	0	2	2	-7	0	58

Mediwound Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-18	-22	-1	4	-9	-13	-19	-6	-30
Operating Cash Flow	-16	-16	-12	8	-6	-8	-11	-10	-13
Investing Cash Flow	1	0	-17	-6	17	3	0	-34	-8
Financing Cash Flow	0	22	0	-1	0	-1	35	22	19
Change in Cash	-13	7	-29	0	10	-6	22	-22	-2

Global Institutional Holdings in Mediwound Ltd

Funds	Holdings
Investors Finance Co PLC	8.02%
Yelin Lapidot Holdings Management Ltd	7.51%
BlackRock Inc	3.96%
Rosalind Advisors, Inc.	3.74%
T. Rowe Price Associates, Inc.	3.45%

See all

Insights on Mediwound Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -13.31M → -2.65M (in $), with an average increase of 402.2% per quarter
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 176.4% return, outperforming this stock by 173.8%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 986.7% return, outperforming this stock by 920.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, MDWD stock has moved down by -1.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 5.70M → 5.42M (in $), with an average decrease of 4.9% per quarter

About Mediwound Ltd

mediwound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds. mediwound’s first innovative biopharmaceutical product, nexobrid®, received marketing authorization from the european medicines agency as well as the israeli and argentinian ministries of health, for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full-thickness thermal burns and was launched in europe israel and argentina. nexobrid represents a new paradigm in burn care management, and clinical trials have demonstrated, with statistical significance, its ability to non-surgically and rapidly remove the eschar earlier and without harming viable tissue. mediwound's second innovative product, escharex®, is a topical biological drug being developed for debridement of chronic and

Organisation	Mediwound Ltd
Headquarters	42 Hayarkon Street, Yavne, Israel, 8122745
Industry	Health Technology
CEO	Mr. Ofer Gonen B.Sc.
E-voting on shares	Click here to vote

Key Management of Mediwound Ltd

Name	Title
Dr. Shmulik Hess Ph.D.	COO & Chief Commercial Officer
Mr. Yaron Meyer Adv.	Executive VP, General Counsel & Corporate Secretary
Dr. Ety Klinger MBA, Ph.D.	Chief Research & Development Officer
Mr. Barry J. Wolfenson	Executive Vice President of Strategy & Corporate Development
Ms. Hagit Mashiach	VP of Human Resources
Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc.	Chief Medical Officer
Mr. Ofer Gonen B.Sc.	Chief Executive Officer
Ms. Hani Luxenburg	Chief Financial Officer

FAQs

What is Mediwound Ltd share price today?

Mediwound Ltd share price today is $17.2 as on December 2, 2025 at 2:29 am IST at the close of the market. Mediwound Ltd share today touched a day high of $17.93 and a low of $17.12.

What is the 52 week high and 52 week low for Mediwound Ltd share?

Mediwound Ltd share touched a 52 week high of $22.51 on June 2, 2025 and a 52 week low of $14.14 on April 7, 2025. Mediwound Ltd stock price today i.e. December 2, 2025 at 2:29 am IST is closed at $17.2,which is 23.57% down from its 52 week high and 21.64% up from its 52 week low.

What is Mediwound Ltd's market capitalisation today?

Mediwound Ltd market capitalisation is $0.00T as on December 2, 2025 at 2:29 am IST.

How to invest in Mediwound Ltd Stock (MDWD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Mediwound Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mediwound Ltd Shares that will get you 0.0872 shares as per Mediwound Ltd share price of $17.2 per share as on December 2, 2025 at 2:29 am IST.

What is the minimum amount required to buy Mediwound Ltd Stock (MDWD) from India?

Indian investors can start investing in Mediwound Ltd (MDWD) shares with as little as ₹89.499 or $1 (as of December 2, 2025 at 5:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹894.99 in Mediwound Ltd stock (as per the Rupee-Dollar exchange rate as on December 2, 2025 at 5:40 am IST). Based on Mediwound Ltd share’s latest price of $17.2 as on December 2, 2025 at 2:29 am IST, you will get 0.5814 shares of Mediwound Ltd. Learn more about fractional shares .

What are the returns that Mediwound Ltd has given to Indian investors in the last 5 years?

Mediwound Ltd stock has given -30.62% share price returns and 21.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?